The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective
By Syed S Mahmood, Daniel Levy, Ramachandran S. Vasan, Thomas J. Wang. 2013
1,447 citations recorded by the source corpus.
Summary On October 11, 2013, the Framingham Heart Study will celebrate 65 years since the examination of its first participant in 1948. During this period, the study has provided substantial insight into the epidemiology of cardiovascular disease and its risk factors. The origin of the study is closely linked to the cardiovascular health of President Franklin D. Roosevelt and his premature death from hypertensive heart disease and stroke in 1945. The present article describes the events leading to the founding of the Framingham Heart Study, and provides a brief historical overview of selected contributions from the study.
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Opportunities and obstacles for deep learning in biology and medicine (2017, background): “In large patient populations, longitudinal analyses such as the Farmingham Heart Study [133] and the Avon Longitudinal Study of Parents and Children[134] have yielded important discoveries about the development of disease and the factors contributing to health status.”
- Axes of a revolution: challenges and promises of big data in healthcare (2020, neutral): “For example, the original Framingham Heart Study 30 , which included residents of the city of Framingham, Massachusetts, and the Nurses’ Health Study 31 , which included registered American nurses, were relatively homogeneous in environmental exposures and education level, respectively.”
- European Society of Cardiology: Cardiovascular Disease Statistics 2017. (2018, background): “The identification of major risk factors that predispose to the development of non-fatal and fatal cardiovascular disease (CVD) was a key contribution of the Framingham Heart Study[19].”